Related references
Note: Only part of the references are listed.Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go?
Qiuyao Huang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Xanthatin inhibits STAT3 and NF-κB signalling by covalently binding to JAK and IKK kinases
Man Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Natural products: An upcoming therapeutic approach to cancer
Sayanta Dutta et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
STAT3, a Master Regulator of Anti-Tumor Immune Response
Cedric Rebe et al.
CANCERS (2019)
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
Longchuan Bai et al.
CANCER CELL (2019)
Natural Sesquiterpene Lactones Enhance Chemosensitivity of Tumor Cells through Redox Regulation of STAT3 Signaling
Elena Butturini et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer
Nethaji Muniraj et al.
CANCERS (2019)
2′-Hydroxycinnamaldehyde inhibits proliferation and induces apoptosis via signal transducer and activator of transcription 3 inactivation and reactive oxygen species generation
Yae Jin Yoon et al.
CANCER SCIENCE (2019)
A new xanthatin analogue 1 beta-hydroxyl-5 alpha-chloro-8-epi-xanthatin induces apoptosis through ROS-mediated ERK/p38 MAPK activation and JAK2/STAT3 inhibition in human hepatocellular carcinoma
Xin-Yi Fang et al.
BIOCHIMIE (2018)
Xanthatin Promotes Apoptosis via Inhibiting Thioredoxin Reductase and Eliciting Oxidative Stress
Ruijuan Liu et al.
MOLECULAR PHARMACEUTICS (2018)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy
Chitra Rajagopal et al.
PHARMACOLOGICAL RESEARCH (2018)
Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
Jenny D. Beebe et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Regulation of Immune Function by Polyphenols
Sujuan Ding et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
New phenylpropanoid derivatives from the fruits of Xanthium sibiricum and their anti-inflammatory activity
Hai Jiang et al.
FITOTERAPIA (2017)
Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor
Joleen M. Hubbard et al.
DRUGS (2017)
Xanthatin anti-tumor cytotoxicity is mediated via glycogen synthase kinase-3β and β-catenin
Li Tao et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Natural Products as Sources of New Drugs from 1981 to 2014
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2016)
Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism
Chengguang Zhao et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Sugiol inhibits STAT3 activity via regulation of transketolase and ROS-mediated ERK activation in DU145 prostate carcinoma cells
Seung-Nam Jung et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Proteome-wide drug and metabolite interaction mapping by thermal-stability profiling
Kilian V. M. Huber et al.
NATURE METHODS (2015)
The role of oxidative stress in anticancer activity of sesquiterpene lactones
Katarzyna Gach et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2015)
Cancer prevention and therapy through the modulation of the tumor microenvironment
Stephanie C. Casey et al.
SEMINARS IN CANCER BIOLOGY (2015)
New Sesquiterpene Lactones from Sunflower Root Exudate as Germination Stimulants for Orobanche cumana
Frank M. Raupp et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2013)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Cytotoxic Sesquiterpene Lactones from Aerial Parts of Xanthium sibiricum
Lun Wang et al.
PLANTA MEDICA (2013)
Identifying Three Ecological Chemotypes of Xanthium strumarium Glandular Trichomes Using a Combined NMR and LC-MS Method
Fangfang Chen et al.
PLOS ONE (2013)
Sesquiterpene lactones from the aerial parts of Xanthium sibiricum and their cytotoxic effects on human cancer cell lines
Van-Binh Bui et al.
PHYTOCHEMISTRY LETTERS (2012)
Xanthane sesquiterpenoids: structure, synthesis and biological activity
Andrea Vasas et al.
NATURAL PRODUCT REPORTS (2011)
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
Subash C. Gupta et al.
CANCER AND METASTASIS REVIEWS (2010)
Cryptotanshinone Inhibits Constitutive Signal Transducer and Activator of Transcription 3 Function through Blocking the Dimerization in DU145 Prostate Cancer Cells
Dae-Seop Shin et al.
CANCER RESEARCH (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Hua Yu et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Opinion - Drug-target residence time and its implications for lead optimization
Robert A. Copeland et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Application of a domino intramolecular enyne metathesis/cross metathesis reaction to the total synthesis of (+)-8-epi-xanthatin
DA Kummer et al.
ORGANIC LETTERS (2005)
A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells
L O Flowers et al.
ONCOGENE (2005)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
Two cytotoxic sesquiterpene lactones from the leaves of Xanthium strumarium and their in vitro inhibitory activity on farnesyltransferase
YS Kim et al.
PLANTA MEDICA (2003)
Share Paper
